Circular Genomics Announced Launch of MindLight™
MindLight™ identifies the presence of a circular RNA biomarker that can predict the likelihood of response to SSRI medication for patients diagnosed with depression Circular...
Tag : digital biomarkers
Canary Speech Receives Patent for Paired Neural Networks Technology
New patent is a major advancement in the capabilities of speech analysis and has the potential to revolutionize various industries including healthcare and customer service...
Imagene Partners with Oracle to Launch CanvOI on OCI
CanvOI Oncology Intelligence (OI) foundation model is designed to decode cancer from biopsy images and drive cancer research forward Oracle and Imagene, a pioneer in AI-based precision...
Lunit Joins Roche’s Digital Pathology Open Environment
Lunit’s AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche’s navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing Lunit (KRX:328130.KQ), a...
Dxcover names first US Scientific Advisory Board Member
Luke Pike MD, DPhil, Radiation Oncologist, joins Dxcover Scientific Advisory Board to advise the company on brain cancer diagnostic early detection clinical applications Dxcover Limited, a...
Noetik Secures $40 Mn Series A to Advance Precision Cancer Therapies
Noetik, an AI-native biotech company leveraging self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, announced today that it closed an oversubscribed...
Jeffrey Elliott Appointed to Quanterix’s Board of Directors
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultra-sensitive biomarker detection, today announced that it appointed Jeffrey Elliott to its Board...
InsideTracker Launches Innovative “Ask InsideTracker” AI Chat Feature
The feature draws on expert-written articles and more than 10 years of data and insights InsideTracker, the leading personalized health platform, today announced the addition...
NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
Investment will allow NeuroTherapia to continue the development of an orally available treatment for Alzheimer’s disease. NeuroTherapia, Inc., a clinical-stage company and Cleveland Clinic Innovations portfolio...
C2N Diagnostics and Unilabs Announce Global Partnership
Partnership Expands Reach of C2N’s Precivity™ Blood Tests in Over 75 Countries to Transform Alzheimer’s Disease Early Diagnosis and Research Agreement Plans to Facilitate a Technology...